Creative Planning Verastem, Inc. Transaction History

Creative Planning

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$2.57 - $4.85 $182,590 - $344,577	-71,047 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.9 - $2.82 $87,400 - $129,719	46,000 Added 183.65%	71,047 $175,000
Q4 2020 Jan 29, 2021	SELL	$1.15 - $2.4 $93,150 - $194,400	-81,000 Reduced 76.38%	25,047 $53,000
Q3 2020 Nov 05, 2020	SELL	$1.11 - $1.68 $4,995 - $7,560	-4,500 Reduced 4.07%	106,047 $128,000
Q2 2020 Jul 23, 2020	SELL	$1.69 - $4.2 $20,280 - $50,400	-12,000 Reduced 9.79%	110,547 $190,000
Q1 2020 May 05, 2020	BUY	$1.26 - $3.38 $6,300 - $16,900	5,000 Added 4.25%	122,547 $324,000
Q4 2019 Jan 30, 2020	BUY	$0.86 - $1.44 $21,457 - $35,928	24,950 Added 26.94%	117,547 $158,000
Q2 2019 Jul 26, 2019	SELL	$1.25 - $3.14 $4,375 - $10,990	-3,500 Reduced 3.64%	92,597 $140,000
Q1 2019 Apr 24, 2019	BUY	$2.79 - $4.09 $11,344 - $16,629	4,066 Added 4.42%	96,097 $284,000
Q4 2018 Feb 01, 2019	BUY	$3.23 - $7.01 $90,440 - $196,280	28,000 Added 43.73%	92,031 $309,000
Q3 2018 Oct 25, 2018	BUY	$6.86 - $9.97 $37,599 - $54,645	5,481 Added 9.36%	64,031 $464,000
Q2 2018 Jul 20, 2018	BUY	$2.88 - $8.67 $39,024 - $117,478	13,550 Added 30.11%	58,550 $403,000
Q1 2018 Apr 18, 2018	BUY	$2.92 - $3.81 $70,080 - $91,440	24,000 Added 114.29%	45,000 $134,000
Q4 2017 Jan 17, 2018	BUY	$2.99 - $4.85 $17,940 - $29,099	6,000 Added 40.0%	21,000 $64,000
Q3 2017 Oct 17, 2017	BUY	$3.01 - $5.41 $45,150 - $81,150	15,000	15,000 $71,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.